Skip to main content
Top
Published in: Supportive Care in Cancer 1/2017

01-01-2017 | Erratum

Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy

Authors: Fausto Roila, David Warr, Paul J. Hesketh, Richard Gralla, Jorn Herrstedt, Karin Jordan, Matti Aapro, Enzo Ballatori, Bernardo Rapoport

Published in: Supportive Care in Cancer | Issue 1/2017

Login to get access

Excerpt

Erratum to: Support Care Cancer
Metadata
Title
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy
Authors
Fausto Roila
David Warr
Paul J. Hesketh
Richard Gralla
Jorn Herrstedt
Karin Jordan
Matti Aapro
Enzo Ballatori
Bernardo Rapoport
Publication date
01-01-2017
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3405-x

Other articles of this Issue 1/2017

Supportive Care in Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine